本页面由Tiger Trade Technology Pte. Ltd.提供服务

再鼎医药

19.22
-0.4700-2.39%
盘后18.70-0.5200-2.71%19:59 EST
成交量:40.89万
成交额:786.39万
市值:21.33亿
市盈率:-10.00
高:19.53
开:18.95
低:18.95
收:19.69
52周最高:44.34
52周最低:15.96
股本:1.11亿
流通股本:1.09亿
量比:0.68
换手率:0.37%
股息:- -
股息率:- -
每股收益(TTM):-1.9229
每股收益(LYR):-2.5984
净资产收益率:-22.56%
总资产收益率:-12.16%
市净率:2.98
市盈率(LYR):-7.40

数据加载中...

2025/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/07

重要事件披露

Form 8-K - Current report
2025/07/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/18

重要事件披露

Form 8-K - Current report
2025/06/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/08

重要事件披露

Form 8-K - Current report
2025/04/19

SEC问询函

Form CORRESP - Correspondence
2025/04/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities